COVID-19 infection is linked to a subsequent heightened risk of poor cardiovascular health and death, particularly among those whose infection is severe requiring hospital admission, finds a large UK Biobank...

On Thursday, the Centers for Disease Control and Prevention (CDC) published an expanded list of who is at increased risk for getting severely ill from COVID-19. In addition to what we already knew–older...

Getting an annual flu shot can save heart failure patients’ lives, according to new research in the American Heart Association’s journal Circulation. Flu season usually begins in the fall...

Five simple medical tests together provide a broader and more accurate assessment of heart-disease risk than currently used methods, cardiologists at UT Southwestern Medical Center found. Combined, results...

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and...

The U.S. Food and Drug Administration today approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Corlanor is approved for use in certain people who have long-lasting...